ArticlePloS one2025

Evaluation of dihydropyranocoumarins as potent inhibitors against triple-negative breast cancer: An integrated of in silico, quantum & molecular modeling approaches.

Abu Yousuf Hossin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.